Institut für Virologie des Universitätsklinikums Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122 Essen,1 Molekulare Immunologie, Gesellschaft für Biotechnologische Forschung (GBF), Macheroder Weg 1, 38124 Braunschweig,2 Abteilung für Immunologie, Paul-Ehrlich Institut, Paul-Ehrlich-Straße 51-59, 63225 Langen, Germany3
Received 9 September 2005/ Accepted 17 January 2006
The type I interferon (IFN) response plays an important role in the control of many viral infections. However, since there is no rodent animal model for human immunodeficiency virus, the antiviral effect of IFN-
and IFN-ß in retroviral infections is not well characterized. In the current study we have used the Friend virus (FV) model to determine the activity of type I interferons against a murine retrovirus. After FV infection of mice, IFN-
and IFN-ß could be measured between 12 and 48 h in the serum. The important role of type I IFN in the early immune defense against FV became evident when mice deficient in IFN type I receptor (IFNAR/) or IFN-ß (IFN-ß/) were infected. The levels of FV infection in plasma and in spleen were higher in both strains of knockout mice than in C57BL/6 wild-type mice. This difference was induced by an antiviral effect of IFN-
and IFN-ß and was most likely mediated by antiviral enzymes as well as by an effect of these IFNs on T-cell responses. Interestingly, the lack of IFNAR and IFN-ß enhanced viral loads during acute and chronic FV infection. Exogenous IFN-
could be used therapeutically to reduce FV replication during acute but not chronic infection. These findings indicate that type I IFN plays an important role in the immediate antiviral defense against Friend retrovirus infection.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|